Showing results (41-50 of 113) with videos related to
Sort By:
Pageof 12
Current Eye Research|November 10, 2009
Antibodies to endogenous tear protein in normal human tearsSusann G Remington, Jean M Crow, J Daniel NelsonInvestigative Ophthalmology & Visual Science|March 18, 2008
Secretoglobins: lacrimal gland-specific rabbit lipophilin mRNAsSusann G Remington, Jean M Crow, J Daniel NelsonInvestigative Ophthalmology & Visual Science|May 11, 1999
Pancreatic lipase-related protein 1 mRNA in female mouse lacrimal glandS G Remington, P H Lima, J D NelsonCurrent Eye Research|December 5, 2009
Human lipocalin-1 association with 3H-testosterone and 3H-estradiolJean M Crow, J Daniel Nelson, Susann G RemingtonPsychiatric Services (Washington, D.C.)|January 6, 2001
Antipsychotic dosing patterns for schizophrenia in three treatment settingsG Remington, C M Shammi, R Sethna, et al.Schizophrenia Research|May 1, 1996
Depression in schizophrenia: a comparison of three measuresA A Collins, G Remington, K Coulter, et al.The American Journal of Psychiatry|February 7, 2001
Increased dopamine d(2) receptor occupancy and elevated prolactin level associated with addition of haloperidol to clozapineS Kapur, P Roy, J Daskalakis, et al.The American Journal of Psychiatry|March 30, 2000
Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophreniaS Kapur, R Zipursky, C Jones, et al.Journal of Clinical Psychopharmacology|February 1, 1993
Acutely psychotic patients receiving high-dose haloperidol therapyG Remington, B Pollock, G Voineskos, et al.Journal of Clinical Psychopharmacology|July 31, 2001
Clomipramine versus haloperidol in the treatment of autistic disorder: a double-blind, placebo-controlled, crossover studyG Remington, L Sloman, M Konstantareas, et al.Pageof 12